# A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

> PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36136154-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36136154-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36136154-dulaglutide-v1.json
- Content SHA-256: `19e084dcced5fb6b4b23c63ba42368bb5f1ecc50b412409b1cd9d618199331ee`

## Claims and source pins

### Headline

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

### Summary

PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

### Paragraph 1

PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

## Sources

<a id="source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6"></a>
- **A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. · retained source version 1:2026-01-27:current:aa0c3498cce656b4c069137f7d3d13b3b097c75d989b1fb12ce62aa03c5db4e3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36136154/) (`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36136154-dulaglutide-v1.json SHA-256: 19e084dcced5fb6b4b23c63ba42368bb5f1ecc50b412409b1cd9d618199331ee.